| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.3 | 1e-15 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.19 | 6e-09 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.19 | 5e-08 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-08 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-07 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.18 | 3e-07 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.2 | 2e-05 |